Safety, Efficacy, and Patient-Reported Outcomes of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Higher-Risk Myelodysplastic Syndrome: A Phase 1b StudyJacqueline S. Garcia, Guillermo Garcia‐Manero, Maria R. Baer et al.|Blood|2020Cited by 58
A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Azacitidine in Treatment-Naïve Patients with Higher-Risk Myelodysplastic SyndromeAndrew H. Wei, Meagan A. Jacoby, Jacqueline S. Garcia et al.|Blood|2019Cited by 46